Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Pacific Edge Limited ( (PFGTF) ) has shared an announcement.
Pacific Edge Limited is undertaking a capital raising initiative through the issuance of new fully paid ordinary shares, aiming to raise approximately NZ$16 million via a non-underwritten placement and up to NZ$5 million through a retail offer structured as a share purchase plan. This move, which includes a proposal to increase director remuneration through share issuance, is not expected to affect the control of the company and aligns with regulatory compliance, potentially strengthening its financial position and operational capabilities.
More about Pacific Edge Limited
Pacific Edge Limited operates in the biotechnology industry, focusing on the development and commercialization of diagnostic tests for the early detection and management of cancer. The company is listed on both the NZX and ASX, indicating its market focus in New Zealand and Australia.
For a thorough assessment of PFGTF stock, go to TipRanks’ Stock Analysis page.